CONMED Corp. buy Needham & Company LLC
Start price
01.02.24
/
50%
€77.50
Target price
01.02.25
€119.25
Performance (%)
-10.97%
End price
02.02.25
€69.00
Summary
This prediction ended on 02.02.25 with a price of €69.00. The prediction for CONMED Corp. disappointed with a performance of -10.97%. Needham___Company_LL has a follow-up prediction for CONMED Corp. where he still thinks CONMED Corp. is a Buy. Dividends of €0.74 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | -1.744% | -1.744% | -51.014% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Needham___Company_LL for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target raised by analysts at Needham & Company LLC from $119.00 to $129.00. They now have a "buy" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten